SFLB saves costs with Helvepharm
Following an agency evaluation, the Swiss generic drug company Helvepharm has decided to partner with Spillmann/Felser/Leo Burnett.
Following an agency evaluation, the Swiss generics company Helvepharm has decided to work with Spillmann/Felser/Leo Burnett (SFLB). In addition to strategic tasks such as brand positioning, SFLB will develop the B2B and B2C campaigns for the young company. According to a media communiqué, the first works are to be seen at the beginning of 2007.
